Prevention of OM-85 on Bronchiectasis Exacerbation

PHASE4CompletedINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

March 1, 2015

Primary Completion Date

November 23, 2018

Study Completion Date

November 23, 2018

Conditions
Bronchiectasis With Acute Exacerbation
Interventions
DRUG

OM-85 BV

two courses of 7mg of OM-85 or matching placebo to take one oral capsule per day for 10 days a month for 3 consecutive months at the beginning of the study, then 3 months later with the same schedule for 1 year.

Trial Locations (2)

100730

Peking Union Medical College Hospital, Beijing

Unknown

Shanghai Tongji University, Shanghai

All Listed Sponsors
collaborator

Peking University

OTHER

collaborator

Capital Medical University

OTHER

collaborator

Tianjin Medical University

OTHER

collaborator

Zhejiang University

OTHER

collaborator

China Medical University, China

OTHER

collaborator

Tongji University

OTHER

collaborator

Wenzhou Medical University

OTHER

lead

Chinese Academy of Medical Sciences

OTHER

NCT01968421 - Prevention of OM-85 on Bronchiectasis Exacerbation | Biotech Hunter | Biotech Hunter